> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Armis Biopharma’s Toe Implant Approved
- URL: https://www.fdaweb.com/armis-biopharmas-toe-implant-approved/
- Published: 2020-11-19T12:00:00.000Z
- Updated: 2026-09-14T16:37:04.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5148131

FDA has approved Armis Biopharma’s VeriFixx Small Bone Implant for the fixation of osteotomies and reconstruction of the lesser toes following correction procedures for hammertoe, claw toe and mallet toe. The company says the device is designed to make such surgical corrections more accessible to patients through shorter time to ambulation, shorter overall recovery time and reduced pain. It uses an alignment fin design and a sub-micron layer of commercially pure titanium molecularly bonded to a polyether ether ketone implant using a high-energy, low-temperature process known as atomic fusion deposition, Armis (XXX SUBSTITUTE XXX) says. The device is also designed to provide ideal fixation alignment and a bone-friendly titanium surface, while “retaining biocompatibility, a modulus of elasticity similar to bone, and excellent radiographic visibility for postoperative imaging,” the company says.